Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

NCT03477474 is registered in ClinicalTrials.gov with Guardant Health, Inc. as lead sponsor.

NCT NCT03477474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer
Lead sponsor
Guardant Health, Inc.
Phase
Observational
Overall status
Terminated
Start date
April 6, 2018
Completion date
September 1, 2019
Enrollment
311 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer metastatic